Mineralys Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
MLYS
CUSIP
603170101
Type
Equity
Class
COM
Num filings
100
Total reported value, excl. options
$529 M
Manager Report Date Value ($000) Shares Option Type